NCT01839968View on ClinicalTrials.gov

Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Acquired Platelet Disorder
Interventions
OTHER

Ex vivo addition of normal platelet rich plasma to prasugrel-treated platelet rich plasma

Trial Locations (1)

1205

University Hospital of Geneva, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT01839968 - Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel | Biotech Hunter | Biotech Hunter